Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
Insects and acarines (mites, ticks) are vectors for a variety of infectious
diseases (e.g., Lyme disease, malaria, equine encephalitis, Rocky Mountain
spotted fever, typhus, yellow fever) in addition to being major
agricultural pests. Many current pesticides and acaricides act at
receptors and ion channels in the nervous systems of arthropods but,
unfortunately, because they lack specificity, these pesticides also have
significant side effects on the mammalian nervous system. In order to
develop highly selective pesticides and acaricides, much more needs to be
known about the structure and pharmacology of insect and acarine hormone
and neuro-transmitter receptors, particularly those which appear from
corresponding receptors in mammals.
Using molecular biology techniques which have been so successful in
elucidating the structure of vertebrate adrenergic receptors, this grant
proposes to clone, from insects and acarines, the family of receptors for
octopamine (thought to be the invertebrate analog to norepinephrine) and,
subsequently, the receptor proteins for dopamine and serotonin (which may
differ pharmacologically from their vertebrate counterparts). Cloning of
octopamine receptors will be facilitated by recent advances in the
Principal Investigator's Laboratory which have led to the development of a
novel, selective, and highly potent octopamine photoaffinity ligand and the
use of this ligand to purify an octopamine receptor protein. An
alternative cloning strategy based upon homology to mammalian adrenergic
receptors will also be used. Once isolated, the structures and
pharmacology of these invertebrate amine receptors will be studied in great
detail, through sequencing, site-directed mutagenesis and eukaryotic
expression. The homology of these receptors to vertebrate amine receptors
will be determined and the distribution of receptors and subtypes, in
insects and acarines (and possibly other phylla of medical significance),
will be determined for various species, tissues, and developmental stages,
thereby providing a rational basis for the development of selective
aminergic pesticides and acaricides.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-March-1990
Project End Date
28-February-1995
Budget Start Date
01-March-1994
Budget End Date
28-February-1995
Project Funding Information for 1994
Total Funding
$198,786
Direct Costs
$115,238
Indirect Costs
$83,548
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Allergy and Infectious Diseases
$198,786
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI029533-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI029533-05
Patents
No Patents information available for 5R01AI029533-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI029533-05
Clinical Studies
No Clinical Studies information available for 5R01AI029533-05
News and More
Related News Releases
No news release information available for 5R01AI029533-05
History
No Historical information available for 5R01AI029533-05
Similar Projects
No Similar Projects information available for 5R01AI029533-05